title: Improved clinical outcome after widespread use of coronary-artery stenting in Canada.
abstract: BACKGROUND
  The introduction and refinement of coronary-artery stenting dramatically changed the practice of percutaneous coronary revascularization in the mid-1990s. We analyzed one-year follow-up data for all percutaneous coronary interventions performed in a large, unselected population in Canada to determine whether the use of coronary stenting has been associated with improved outcomes.
  
  
  METHODS
  Prospectively collected data on all percutaneous coronary interventions performed on residents of British Columbia, Canada, between April 1994 and June 1997 were linked to province-wide health care data bases to provide the date of the following end points: subsequent target-vessel revascularization, myocardial infarction, and death. Baseline characteristics and procedural variables were identified and Kaplan-Meier survival curves were generated for 9594 procedures divided into seven groups, one for each sequential half-year period.
  
  
  RESULTS
  The overall burden of coexisting illnesses remained stable throughout the study period. A large increase in the rate of coronary stenting (from 14.2 percent in the period from April to June 1994 to 58.7 percent in the period from January to June 1997) was associated with a significant reduction in the rate of adverse cardiac events at one year (from 28.8 percent to 22.8.percent; adjusted relative risk, 0.79; 95 percent confidence interval, 0.69 to 0.90; P<0.001). This reduction in adverse events was exclusively due to a large reduction in subsequent target-vessel revascularization (from 24.4 percent to 17.0 percent; adjusted relative risk, 0.72; 95 percent confidence interval, 0.62 to 0.83; P<0.001) without significant changes in the overall rates of myocardial infarction (5.4 percent, P=0.28) or death (3.9 percent, P=0.65).
  
  
  CONCLUSIONS
  The need for target-vessel revascularization during one year of follow-up decreased after percutaneous coronary intervention during the mid-1990s. The reduction was coincident with the introduction and subsequent widespread use of coronary stenting.
authors.affiliation: Vancouver General Hospital, British Columbia, Canada.
authors.forename: J M
authors.initials: JM
authors.lastname: Rankin
authors.forename: J J
authors.initials: JJ
authors.lastname: Spinelli
authors.forename: R G
authors.initials: RG
authors.lastname: Carere
authors.forename: D R
authors.initials: DR
authors.lastname: Ricci
authors.forename: I M
authors.initials: IM
authors.lastname: Penn
authors.forename: J D
authors.initials: JD
authors.lastname: Hilton
authors.forename: M A
authors.initials: MA
authors.lastname: Henderson
authors.forename: R I
authors.initials: RI
authors.lastname: Hayden
authors.forename: C E
authors.initials: CE
authors.lastname: Buller
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000706:statistics & numerical data* / Q000639:trends; D002170:Canada / Q000453:epidemiology; D003327:Coronary Disease / Q000401:mortality / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D016016:Proportional Hazards Models; D055502:Secondary Prevention; D015607:Stents / Q000706:statistics & numerical data* / Q000639:trends; D016019:Survival Analysis